OpenLegislation

Annex III

United Kingdom

Original text. Later amendments are not shown.

Index NoInternational Chemical IdentificationEC NoCAS NoClassificationLabellingSpecific Conc. Limits,M — FactorsNotes
Hazard Class and Category Code(s)Hazard statement Code(s)Pictogram, Signal Word Code(s)Hazard statement Code(s)Suppl. Hazard statement Code(s)
031-001-00-4gallium arsenide215-114-81303-00-0Carc. 1BH350GHS08H350
STOT RE 1H372 (respiratory and haematopoietic systems)DgrH372 (respiratory and haematopoietic systems)
050-025-00-6trichloromethylstannane213-608-8993-16-8Repr. 2H361d

GHS08

Wng

H361d
050-026-00-12-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate260-828-557583-34-3Repr. 2H361d

GHS08

Wng

H361d
050-027-00-72-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate239-622-415571-58-1Repr. 1BH360D

GHS08

Dgr

H360D
601-087-00-32,4,4-trimethylpentene246-690-925167-70-8Flam. Liq. 2H225GHS02H225D
Asp. Tox. 1H304GHS07H304
STOT SE 3H336

GHS08

Dgr

H336
606-145-00-1

sulcotrione (ISO);

2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione

99105-77-8Repr. 2H361dGHS08H361d

M = 1

M = 10

STOT RE 2H373 (kidneys)GHS07H373 (kidneys)
Skin Sens. 1AH317GHS09H317
Aquatic Acute 1H400Wng
Aquatic Chronic 1H410H410
607-699-00-7

bifenthrin (ISO);

(2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate

82657-04-3Carc. 2H351GHS06H351

M = 10 000

M = 100 000

Acute Tox. 3H331GHS08H331
Acute Tox. 2H300GHS09H300
STOT RE 1H372 (nervous system)DgrH372 (nervous system)
Skin Sens. 1BH317H317
Aquatic Acute 1H400
Aquatic Chronic 1H410H410
607-700-00-0

indoxacarb (ISO);

methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1]

173584-44-6 [1]Acute Tox. 3H301GHS06H301

M = 1

M = 1

Acute Tox. 4H332GHS08H332
STOT RE 1H372 (blood, nervous system, heart)GHS09H372 (blood, nervous system, heart)
Skin Sens. 1BH317DgrH317
Aquatic Acute 1H400
Aquatic Chronic 1H410H410

reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25;

methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2]

144171-61-9 [2]
607-702-00-1dihexyl phthalate201-559-584-75-3Repr. 1BH360FD

GHS08

Dgr

H360FD
607-703-00-7ammoniumpentadeca- fluorooctanoate223-320-43825-26-1Carc. 2H351GHS08H351
Repr. 1BH360DGHS07H360D
Lact.H362GHS05H362
Acute Tox. 4H332DgrH332
Acute Tox. 4H302H302
STOT RE 1H372 (liver)H372 (liver)
Eye Dam.1H318H318
607-704-00-2perfluorooctanoic acid206-397-9335-67-1Carc. 2H351GHS08H351
Repr. 1BH360DGHS07H360D
Lact.H362GHS05H362
Acute Tox. 4H332DgrH332
Acute Tox. 4H302H302
STOT RE 1H372 (liver)H372 (liver)
Eye Dam. 1H318H318
612-282-00-8octadecylamine204-695-3124-30-1Asp. Tox. 1H304GHS05H304

M = 10

M = 10

STOT RE 2H373 (gastro-intestinal tract, liver, immune system)GHS08H373 (gastro-intestinal tract, liver, immune system)
Skin Irrit. 2H315GHS09H315
Eye Dam. 1H318DgrH318
Aquatic Acute 1H400
Aquatic Chronic 1H410H410
612-283-00-3(Z)-octadec-9-enylamine204-015-5112-90-3Acute Tox. 4H302GHS05H302

M = 10

M = 10

Asp Tox. 1H304GHS07H304
STOT SE 3H335GHS08H335
STOT RE 2H373 (gastro-intestinal tract, liver, immune system)GHS09H373 (gastro-intestinal tract, liver, immune system)
Skin Corr. 1BH314DgrH314
Aquatic Acute 1H400
Aquatic Chronic 1H410H410
612-284-00-9amines, hydrogenated tallow alkyl262-976-661788-45-2Asp Tox. 1H304GHS08H304

M = 10

M = 10

STOT RE 2H373 (gastro-intestinal tract, liver, immune system)GHS05H373 (gastro-intestinal tract, liver, immune system)
Skin Irrit. 2H315GHS09H315
Eye Dam. 1H318DgrH318
Aquatic Acute 1H400
Aquatic Chronic 1H410H410
612-285-00-4amines, coco alkyl262-977-161788-46-3Acute Tox. 4H302GHS05H302

M = 10

M = 10

Asp. Tox. 1H304GHS07H304
STOT SE 3H335GHS08H335
STOT RE 2H373 (gastro-intestinal tract, liver, immune system)GHS09H373 (gastro-intestinal tract, liver, immune system)
Skin Corr. 1BH314DgrH314
Aquatic Acute 1H400
Aquatic Chronic 1H410H410
612-286-00-Xamines, tallow alkyl263-125-161790-33-8Acute Tox. 4H302GHS05H302

M = 10

M = 10

Asp. Tox. 1H304GHS07H304
STOT RE 2H373 (gastro-intestinal tract, liver, immune system)GHS08H373 (gastro-intestinal tract, liver, immune system)
Skin Corr. 1BH314GHS09H314
Aquatic Acute 1H400Dgr
Aquatic Chronic 1H410H410
616-206-00-4

flufenoxuron (ISO);

1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea

417-680-3101463-69-8Lact.H362GHS09H362

M = 10 000

M = 10 000

Aquatic Acute 1H400Wng
Aquatic Chronic 1H410H410
616-207-00-Xpolyhexamethylene biguanide hydrochloride27083-27-8 or 32289-58-0Carc. 2H351GHS05H351

M = 10

M = 10

Acute Tox. 4H302GHS07H302
STOT RE 1H372 (respiratory tract) (inhalation)GHS08H372 (respiratory tract) (inhalation)
Eye Dam. 1H318GHS09H318
Skin Sens. 1BH317DgrH317
Aquatic Acute 1H400
Aquatic Chronic 1H410H410
616-208-00-5

N-ethyl-2-pyrrolidone;

1-ethylpyrrolidin-2-one

220-250-62687-91-4Repr. 1BH360D

GHS08

Dgr

H360D
616-209-00-0

amidosulfuron (ISO);

3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea

407-380-0120923-37-7Aquatic Acute 1H400GHS09

M = 100

M = 100

Aquatic Chronic 1H410WngH410
616-210-00-6

tebufenpyrad (ISO);

N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1Hpyrazole-5- carboxamide

119168-77-3Acute Tox. 3H301GHS06H301

M = 10

M = 10

Acute Tox. 4H332GHS08H332
STOT RE 2H373 (gastro-intestinal tract) (Oral)GHS09H373 (gastro-intestinal tract) (Oral)
Skin Sens. 1BH317DgrH317
Aquatic Acute 1H400
Aquatic Chronic 1H410H410
616-211-00-1

proquinazid (ISO);

6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one

189278-12-4Carc. 2H351GHS08H351

M = 1

M = 10

Aquatic Acute 1H400GHS09
Aquatic Chronic 1H410WngH410